• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Lot Number VMFC230423
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation of Vessels (2135); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 08/02/2023
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that during a left atrial appendage occlusion (laao) procedure, a perforation, pericardial effusion and tamponade occurred.The transseptal puncture was performed; however it was observed after that the versacross rf wire was in the aorta.When checked for effusion, it was present.Physician then performed pericardiocentesis and pulled 400 cc units of blood.Additional surgery consultation was requested to pull the versacross rf wire out, however the effusion came back.Procedure was cancelled and physician then performed cardiac surgery to treat effusion.The hole was patched and appendage was clipped.The patient was admitted to hospital beyond standard of care, it was discarded (date unknown) and expected to fully recover.The device is not expected to be returned for analysis.No other issues were noted.Patient had a very dilated aorta and floppy septum.The transseptal puncture was completed prior to perforation that led to pericardial effusion.It is believed that the dilated aorta tissue connecting to the left atrium was "stretched out and very friable" against the wire causing the perforation.Act was not documented.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17624776
MDR Text Key321966900
Report Number2124215-2023-45119
Device Sequence Number1
Product Code DRE
UDI-Device Identifier00685447012573
UDI-Public00685447012573
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberVMFC230423
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/02/2023
Initial Date FDA Received08/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/26/2023
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention;
-
-